English

Eligibility Type 2 Diabetes Mellitus NCT00548808

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes mellitus
Description

Diabetes Mellitus, Non-Insulin-Dependent

Data type

boolean

Alias
UMLS CUI [1]
C0011860
receiving oral antihyperglycemic medications (including metformin) without insulin injection in the last 90 days
Description

Hypoglycemic Agents Oral | Metformin | Insulin injection Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C0020616
UMLS CUI [1,2]
C1527415
UMLS CUI [2]
C0025598
UMLS CUI [3,1]
C0199782
UMLS CUI [3,2]
C0332197
hemoglobin a1c (hba1c) equal to or greater than 7.0% but less than 11.0%
Description

Hemoglobin A1c measurement

Data type

boolean

Alias
UMLS CUI [1]
C0474680
willing to receive insulin injection while continuing to take the prestudy oral antihyperglycemic medications
Description

Insulin injection Willing | Hypoglycemic Agents Oral Continuing

Data type

boolean

Alias
UMLS CUI [1,1]
C0199782
UMLS CUI [1,2]
C0600109
UMLS CUI [2,1]
C0020616
UMLS CUI [2,2]
C1527415
UMLS CUI [2,3]
C0549178
able to perform self monitoring of blood glucose
Description

Blood Glucose Self-Monitoring Perform Able

Data type

boolean

Alias
UMLS CUI [1,1]
C0005803
UMLS CUI [1,2]
C0884358
UMLS CUI [1,3]
C0085732
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
are taking any other glucose-lowering agents other than metformin, sulfonylurea or thiazolidinedione (pioglitazone)
Description

Hypoglycemic Agents | Exception Metformin | Exception Sulfonylureas | Exception Thiazolidinediones | Exception Pioglitazone

Data type

boolean

Alias
UMLS CUI [1]
C0020616
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0025598
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0038766
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C1257987
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0071097
have taken acarbose, miglitol, pramlintide, exenatide, repaglinide, or nateglinide in the past 6 weeks, or for a total of 30 days or more, in the last 24 weeks
Description

Acarbose | miglitol | Pramlintide | exenatide | repaglinide | nateglinide

Data type

boolean

Alias
UMLS CUI [1]
C0050393
UMLS CUI [2]
C0066535
UMLS CUI [3]
C0537551
UMLS CUI [4]
C0167117
UMLS CUI [5]
C0246689
UMLS CUI [6]
C0903898
have a body mass index greater than 35 kg/m2
Description

Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C1305855
history or presence of kidney disease
Description

Kidney Disease

Data type

boolean

Alias
UMLS CUI [1]
C0022658
have cardiac disease (class iii or iv)
Description

Heart Disease New York Heart Association Classification

Data type

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C1275491
Back to the top of the page

Similar models

Eligibility Type 2 Diabetes Mellitus NCT00548808

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes mellitus
boolean
C0011860 (UMLS CUI [1])
Hypoglycemic Agents Oral | Metformin | Insulin injection Absent
Item
receiving oral antihyperglycemic medications (including metformin) without insulin injection in the last 90 days
boolean
C0020616 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0025598 (UMLS CUI [2])
C0199782 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Hemoglobin A1c measurement
Item
hemoglobin a1c (hba1c) equal to or greater than 7.0% but less than 11.0%
boolean
C0474680 (UMLS CUI [1])
Insulin injection Willing | Hypoglycemic Agents Oral Continuing
Item
willing to receive insulin injection while continuing to take the prestudy oral antihyperglycemic medications
boolean
C0199782 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
C0020616 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0549178 (UMLS CUI [2,3])
Blood Glucose Self-Monitoring Perform Able
Item
able to perform self monitoring of blood glucose
boolean
C0005803 (UMLS CUI [1,1])
C0884358 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Hypoglycemic Agents | Exception Metformin | Exception Sulfonylureas | Exception Thiazolidinediones | Exception Pioglitazone
Item
are taking any other glucose-lowering agents other than metformin, sulfonylurea or thiazolidinedione (pioglitazone)
boolean
C0020616 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0025598 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0038766 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C1257987 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0071097 (UMLS CUI [5,2])
Acarbose | miglitol | Pramlintide | exenatide | repaglinide | nateglinide
Item
have taken acarbose, miglitol, pramlintide, exenatide, repaglinide, or nateglinide in the past 6 weeks, or for a total of 30 days or more, in the last 24 weeks
boolean
C0050393 (UMLS CUI [1])
C0066535 (UMLS CUI [2])
C0537551 (UMLS CUI [3])
C0167117 (UMLS CUI [4])
C0246689 (UMLS CUI [5])
C0903898 (UMLS CUI [6])
Body mass index
Item
have a body mass index greater than 35 kg/m2
boolean
C1305855 (UMLS CUI [1])
Kidney Disease
Item
history or presence of kidney disease
boolean
C0022658 (UMLS CUI [1])
Heart Disease New York Heart Association Classification
Item
have cardiac disease (class iii or iv)
boolean
C0018799 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Back to the top of the page